HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Compound Tufuling Granules () regulate glucose transporter 9 expression in kidney to influence serum uric acid level in hyperuricemia mice.

AbstractOBJECTIVE:
To explore the effect of Compound Tufuling Granules (, CTG) on regulating glucose transporter 9 (GLUT9) expression in the kidney to influence the uric acid excretion by the kidney and serum uric acid (SUA) level in hyperuricemia mice.
METHODS:
Sixty Kunming male mice were randomly divided into the control group, model group, benzbromarone group, and CTG high-, middle- and lowdose groups. The yeast extract and uricase inhibition method were used to build hyperuricemia model, and the corresponding drugs were administrated on the 7th day. On the 21st day the 24-h urine was collected, on the 22nd day the blood was collected, the SUA level was detected by uricase colorimetry, and the mRNA and protein expressions of GLUT9 were detected by quantitative real-time polymerase chain reaction and Western blot, respectively.
RESULTS:
Compared with the model group, the levels of SUA and the mRNA and protein expressions of GLUT9 were signifificantly decreased, and the fraction excretion of uric acid (FEUA) was significantly increased in the CTG groups and benzbromarone group (all P<0.05). There was no significant difference in the above indicators between the CTG high-dose group and benzbromarone group (P>0.05). SUA is positively related to the GLUT9 mRNA and protein expressions in the kidney (P<0.05 or P<0.01).
CONCLUSIONS:
CTG can signifificantly reduce the SUA and increase the FEUA. In addition, CTG can effectively inhibit the mRNA and protein expressions of GLUT9 in the kidney of hyperuricemia mice to inhibit the uric acid re-absorption, promote uric acid excretion and reduce SUA.
AuthorsYing-Wan Liu, Wei-Feng Sun, Xian-Xian Zhang, Jing Li, Huan-Huan Zhang
JournalChinese journal of integrative medicine (Chin J Integr Med) Vol. 21 Issue 11 Pg. 823-9 (Nov 2015) ISSN: 1672-0415 [Print] China
PMID25864117 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: